Replies to post #63925 on NorthWest Biotherapeutics Inc (NWBO)

[sentiment_stocks]

I guess they could have another trial planned with BMS / BMY at MD Anderson in addition to the one planned for UCLA with BMS. But the PR does state 3 different combo treatments for three different cancers in three different trials. Initially I had recently posted I though the other two might be with Merck and another CI - all for recurrent GBM... to see which worked best. However, I made a mistake as it can't be recurrent GBM in all three as they state the cancers will be different.

It's still very possible they all will be with L, but perhaps using L in another indication where the tumor is first removed.

[sentiment_stocks]

I completely agree.

It is my very clear understanding as well that there will be a BMY/NWBO trial at UCLA in recurrent GBM because Dr. Prins talked about it as well. :)

And yes, they could do another trial pairing Opdivo with say Direct instead of L... possibly at MD Anderson. I am really so not fond of MD Anderson but I know they like Dr. Subbiah a lot. So maybe that one could be, wherever it is done, for non-small-cell lung cancer?

That's a different "combination treatment" (but still with BMY but at another location - hence, different parties)... which still fits with the wording.

Merck may fit in there too. Of BMY I am sure of. Of Merck, I'm not.